Middle East and Africa Liquid biopsy market from 2013 to 2022

Middle East and Africa Liquid biopsy Market is projected to grow at a CAGR of 23.0% and is expected to reach US$ 1,534 million by 2022. In Middle East and Africa Liquid biopsy Market, United Arab Emirates accounted for the largest market share in 2016.

Middle East and Africa Liquid biopsy is one of the fastest market. The liquid biopsy technique provides a comparative noninvasive, highly sensitive and information rich profile of the disease in a time frame which is half of the conventional tissue biopsy. The Middle East and Africa Liquid biopsy market comprises of countries namely United Arab Emirates, Saudi Arabia, Egypt and Rest of Middle East and Africa. United Arab Emirates is the largest market for liquid biopsy in Middle East and Africa followed by Saudi Arabia and Egypt.

The market is also segmented by biomaker type including Circulating Tumor Cells (CTCs), Circulating Tumor DNA (CtDNA), Extracellular Vesicles (EVs) and others. Circulating Tumor Cells (CTCs) accounted for the largest market share.  Circulating Tumor DNA (CtDNA) is the fastest growing market.

According to therapeutic application, the market in Middle East and Africa is segmented into Cancer, Reproductive health, others. Cancer accounted for the largest market share and reproductive health is the fastest growing market.

According to type of sample, liquid biopsy market in segmented into Blood, Urine and others. Blood accounts for the largest market share with urine as fastest growing segment.

According to end user, the market is segmented into Hospitals and Laboratories, Academic and Research Centers and others. Hospitals and Laboratories accounted for the largest market share.

Middle East and Africa Liquid biopsy Market, By Country, 2016 & 2022 (%)

Middle East and Africa Liquid biopsy market statistical report published by Market Research future contains a brief overview of Middle East and Africa Liquid biopsy market. By country, market is segmented into countries namely United Arab Emirates, Saudi Arabia, Egypt and Rest of Middle East and Africa. United Arab Emirates commands the largest share and is expected to grow continuously during the forecasted period of 2013-2022. The report analyzed the Middle East and Africa Liquid biopsy market and presents systematic data of market share on the basis of segments and countries, and its growth rate for 2014 to 2017, along with forecast till 2022.

Market Research future through this report aims to provide understanding of the Middle East and Africa Liquid biopsy market on the basis of segments & countries, and also assists identification of ongoing trends along with anticipated growth during the forecasted period. For this report, extensive primary research was conducted to gain a deeper insight of the market performance. Various industry experts and Key Opinion Leaders (KOLs) were contacted and interviewed to get an idea of Middle East and Africa Liquid biopsy market.
List of Tables

TABLE 1    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY COUNTRY, 2014-2022 ($ MILLION)
TABLE 2    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022  ($ MILLION)
TABLE 3    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS,  2014-2022 ($ MILLION)
TABLE 4    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)
TABLE 5    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)
TABLE 6    UAE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)
TABLE 7    UAE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)
TABLE 8    UAE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)
TABLE 9    UAE LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)
TABLE 10    SAUDI ARABIA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)
TABLE 11    SAUDI ARABIA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022  ($ MILLION)
TABLE 12    SAUDI ARABIA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)
TABLE 13    SAUDI ARABIA LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)
TABLE 14    EGYPT LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022 ($ MILLION)
TABLE 15    EGYPT LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)
TABLE 16    EGYPT LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022 ($ MILLION)
TABLE 17    EGYPT LIQUID BIOPSY MARKET BY END USERS, 2014-2022 ($ MILLION)
TABLE 18    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2014-2022  ($ MILLION)
TABLE 19    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)
TABLE 20    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2014-2022  ($ MILLION)
TABLE 21    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY END USERS, 2014-2022  ($ MILLION)

List of Figures

FIGURE 1    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET, MARKET SHARE BY COUNTRY, 2016 (%)
FIGURE 2    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY COUNTRY, 2016 ($ MILLION)
FIGURE 3    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)
FIGURE 4    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016  ($ MILLION)
FIGURE 5    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)
FIGURE 6    MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)
FIGURE 7    UAE LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)
FIGURE 8    UAE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)
FIGURE 9    UAE LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)
FIGURE 10    UAE LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)
FIGURE 11    SAUDI ARABIA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)
FIGURE 12    SAUDI ARABIA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)
FIGURE 13    SAUDI ARABIA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)
FIGURE 14    SAUDI ARABIA LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)
FIGURE 15    EGYPT LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 ($ MILLION)
FIGURE 16    EGYPT LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)
FIGURE 17    EGYPT LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016 ($ MILLION)
FIGURE 18    EGYPT LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)
FIGURE 19    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016  ($ MILLION)
FIGURE 20    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2016 ($ MILLION)
FIGURE 21    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY SAMPLE TYPE, 2016  ($ MILLION)
FIGURE 22    REST OF MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY END USERS, 2016 ($ MILLION)